Hedge Fund - OrbiMed Advisors

Pfizer Inc (PFE) 

Holding History Records
No. Filing Period Value % of Portfolio Number of Shares Avg. Quarterly Share Price
1 2023 - Q1 (2023-03-31) $0 0% 0 $43.19
2 2022 - Q4 (2022-12-31) $71,408,064 1.36% 1,393,600 $47.94
3 2022 - Q3 (2022-09-30) $113,732,000 2.11% 2,599,000 $48.59
4 2022 - Q2 (2022-06-30) $143,868,000 2.6% 2,744,000 $50.96
5 2022 - Q1 (2022-03-31) $202,188,000 3.27% 3,905,500 $51.89
6 2021 - Q4 (2021-12-31) $154,439,000 1.98% 2,615,400 $49.55
7 2021 - Q1 (2021-03-31) $0 0% 0 $35.51
8 2020 - Q4 (2020-12-31) $133,127,000 1.16% 3,616,600 $36.68
9 2020 - Q2 (2020-06-30) $0 0% 0 $33.97
10 2020 - Q1 (2020-03-31) $98,315,000 1.65% 3,174,753.4 $34.07
11 2019 - Q1 (2019-03-31) $0 0% 0 $40.05
12 2018 - Q4 (2018-12-31) $26,286,000 0.48% 634,718.8 $41.51
13 2018 - Q3 (2018-09-30) $29,470,000 0.35% 704,809.8 $38.50
14 2018 - Q2 (2018-06-30) $35,627,000 0.42% 1,035,028 $34.17
15 2018 - Q1 (2018-03-31) $34,851,000 0.43% 1,035,028 $34.38
16 2017 - Q4 (2017-12-31) $35,568,000 0.44% 1,035,028 $34.10
17 2017 - Q3 (2017-09-30) $87,779,000 0.83% 2,591,575.2 $32.14
18 2017 - Q2 (2017-06-30) $82,591,000 0.86% 2,591,575.2 $31.54
19 2017 - Q1 (2017-03-31) $184,943,000 2.09% 5,698,029.4 $31.53
20 2016 - Q4 (2016-12-31) $167,853,000 2.13% 5,446,966.6 $30.53
21 2016 - Q3 (2016-09-30) $119,636,000 1.36% 3,722,938.8 $33.44
22 2016 - Q2 (2016-06-30) $149,421,000 1.55% 4,472,859.8 $31.92
23 2016 - Q1 (2016-03-31) $122,176,000 1.28% 4,344,588 $28.56
24 2015 - Q4 (2015-12-31) $133,123,000 1.2% 4,346,696 $31.46
25 2015 - Q3 (2015-09-30) $118,196,000 1.19% 3,966,202 $32.06
26 2015 - Q2 (2015-06-30) $102,367,000 0.85% 3,217,862 $32.59
27 2015 - Q1 (2015-03-31) $103,813,000 0.88% 3,145,136 $31.79
28 2014 - Q4 (2014-12-31) $85,943,000 0.82% 2,907,986 $28.67
29 2014 - Q3 (2014-09-30) $78,952,000 0.82% 2,814,180 $28.07
30 2014 - Q2 (2014-06-30) $121,154,000 1.42% 4,302,428 $28.51
31 2014 - Q1 (2014-03-31) $117,591,000 1.44% 3,858,694 $29.82
32 2013 - Q4 (2013-12-31) $108,828,000 1.59% 3,744,862 $29.10
33 2013 - Q3 (2013-09-30) $115,199,000 2.05% 4,226,961.6 $27.21
34 2013 - Q2 (2013-06-30) $137,341,000 2.91% 5,168,078.2 $27.63
35 2013 - Q1 (2013-03-31) $266,060,000 6.18% 9,716,826 $25.94
36 2012 - Q4 (2012-12-31) $223,507,000 6.89% 9,393,248 $23.73
37 2012 - Q3 (2012-09-30) $221,215,000 6.35% 9,382,708 $22.58
38 2012 - Q1 (2012-03-31) $234,670,000 6.97% 10,922,602 $20.49
39 2011 - Q4 (2011-12-31) $174,323,000 5.71% 8,490,602.4 $18.73
40 2011 - Q3 (2011-09-30) $137,110,000 5.08% 8,173,875.4 $17.73
41 2011 - Q2 (2011-06-30) $138,626,000 2.57% 7,092,787.6 $19.54
42 2011 - Q1 (2011-03-31) $125,983,000 4.24% 6,537,962 $18.11
43 2010 - Q4 (2010-12-31) $108,860,000 3.92% 6,552,718 $16.29

The displayed share prices are average quarterly stock market prices.

The share numbers are adjusted according to following stock splits:

  1. 1054.0000:1000.0000 on 2020-11-17